Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Louis Bourgeois

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|March 20, 2023
Oral inactivated whole cell vaccine for mucosal immunization: ETVAX case studyRichard I Walker, A Louis Bourgeois
Vaccine|March 19, 2016
Status of vaccine research and development for enterotoxigenic Escherichia coliA Louis Bourgeois, Thomas F Wierzba, Richard I Walker
Vaccine|October 9, 2017
Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE ConferenceRichard I Walker, Thomas F Wierzba, Sachin Mani, et al.
Microorganisms|June 27, 2024
Special Issue on Enterotoxigenic <i>Escherichia coli</i> (ETEC) Vaccines: ETEC Infection and Vaccine-Mediated ImmunityFrederick J Cassels, Ibrahim Khalil, A Louis Bourgeois, et al.
Gut Microbes|March 1, 2021
Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic <i>E. coli</i> infection and impact on intestinal colonization and ETEC specific immune responses in an experimental human challenge modelJessica Brubaker, Xueyan Zhang, A Louis Bourgeois, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2007
Systemic pharmacokinetics of rifaximin in volunteers with shigellosisDavid N Taylor, Robin McKenzie, Anna Durbin, et al.
Plos Neglected Tropical Diseases|February 20, 2014
Estimating diarrheal illness and deaths attributable to Shigellae and enterotoxigenic Escherichia coli among older children, adolescents, and adults in South Asia and AfricaLaura M Lamberti, A Louis Bourgeois, Christa L Fischer Walker, et al.
Human Vaccines & Immunotherapeutics|July 31, 2019
Adjuvant effect of enterotoxigenic <i>Escherichia coli</i> (ETEC) double-mutant heat-labile toxin (dmLT) on systemic immunogenicity induced by the CFA/I/II/IV MEFA ETEC vaccine: Dose-related enhancement of antibody responses to seven ETEC adhesins (CFA/I, CS1-CS6)Hyesuk Seo, Ti Lu, Sachin Mani, et al.
Journal of Clinical Microbiology|September 1, 2006
Enterotoxigenic Escherichia coli with STh and STp genotypes is associated with diarrhea both in children in areas of endemicity and in travelersIngrid Bölin, Gudrun Wiklund, Firdausi Qadri, et al.
Vaccine|June 7, 2017
Developing and utilizing controlled human models of infectionChad K Porter, A Louis Bourgeois, Robert W Frenck, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|March 20, 2023
Oral inactivated whole cell vaccine for mucosal immunization: ETVAX case studyRichard I Walker, A Louis Bourgeois
Vaccine|March 19, 2016
Status of vaccine research and development for enterotoxigenic Escherichia coliA Louis Bourgeois, Thomas F Wierzba, Richard I Walker
Vaccine|October 9, 2017
Vaccines against Shigella and enterotoxigenic Escherichia coli: A summary of the 2016 VASE ConferenceRichard I Walker, Thomas F Wierzba, Sachin Mani, et al.
Microorganisms|June 27, 2024
Special Issue on Enterotoxigenic <i>Escherichia coli</i> (ETEC) Vaccines: ETEC Infection and Vaccine-Mediated ImmunityFrederick J Cassels, Ibrahim Khalil, A Louis Bourgeois, et al.
Gut Microbes|March 1, 2021
Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic <i>E. coli</i> infection and impact on intestinal colonization and ETEC specific immune responses in an experimental human challenge modelJessica Brubaker, Xueyan Zhang, A Louis Bourgeois, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2007
Systemic pharmacokinetics of rifaximin in volunteers with shigellosisDavid N Taylor, Robin McKenzie, Anna Durbin, et al.
Plos Neglected Tropical Diseases|February 20, 2014
Estimating diarrheal illness and deaths attributable to Shigellae and enterotoxigenic Escherichia coli among older children, adolescents, and adults in South Asia and AfricaLaura M Lamberti, A Louis Bourgeois, Christa L Fischer Walker, et al.
Human Vaccines & Immunotherapeutics|July 31, 2019
Adjuvant effect of enterotoxigenic <i>Escherichia coli</i> (ETEC) double-mutant heat-labile toxin (dmLT) on systemic immunogenicity induced by the CFA/I/II/IV MEFA ETEC vaccine: Dose-related enhancement of antibody responses to seven ETEC adhesins (CFA/I, CS1-CS6)Hyesuk Seo, Ti Lu, Sachin Mani, et al.
Journal of Clinical Microbiology|September 1, 2006
Enterotoxigenic Escherichia coli with STh and STp genotypes is associated with diarrhea both in children in areas of endemicity and in travelersIngrid Bölin, Gudrun Wiklund, Firdausi Qadri, et al.
Vaccine|June 7, 2017
Developing and utilizing controlled human models of infectionChad K Porter, A Louis Bourgeois, Robert W Frenck, et al.
Pageof 7